Globe Newswire

MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 2024, to shareholders of record at the close of business on May 31, 2024. This second quarter 2024 dividend compares with the first quarter 2024 dividend of $0.045 per common share. This dividend... (continue reading...)

SHANGHAI, China, May 17, 2024 (GLOBE NEWSWIRE) -- Intchains Group Limited (Nasdaq: ICG) (“we,” or the “Company”), a provider of integrated solutions consisting of high-performance computing ASIC chip-based solutions products and a corporate holder of cryptocurrencies based on Ethereum, or ETH, today announced its unaudited financial results for the first quarter ended March 31, 2024.

First Quarter 2024 Operating and Financial Highlights

• Sales volume of ASIC... (continue reading...)

BURNABY, British Columbia, May 16, 2024 (GLOBE NEWSWIRE) -- The United Steelworkers union (USW) District 3 is committed to reconciliation with B.C. First Nations and supports Bill 25, Haida Nation Recognition Amendment Act, 2024. The “Rising Tide” Haida Title Lands Agreement is a major step forward. 

“We acknowledge our role in addressing the legacy of colonialism and we support the B.C. government doing the same,” said USW District 3 Director, Scott... (continue reading...)

First quarter revenue grew 33% year-over-year to $125 million

Net loss driven entirely by one-time items; Company delivers increased non-GAAP profitability year-over-year excluding one-time items

BETHESDA, Md., May 16, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (NASDAQ: AILE) (“iLearningEngines”, “ILE”, or “the Company”), a leader in AI-powered learning automation and information intelligence for corporate and educational use, today announced... (continue reading...)

CHICAGO, May 16, 2024 (GLOBE NEWSWIRE) -- Today, the Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, takes a bold step forward in addressing health disparities by announcing the launch of the Coalition for Clinical Trial Equity as part of their latest phase of the Ignore No More Initiative, ACTe Now!: Roadmap 2 Progress. This initiative aims to... (continue reading...)